200 results on '"Do, Albert"'
Search Results
2. Screening, Diagnosis, and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD): Application of Society Guidelines to Clinical Practice
3. Concentration-dependent transcriptional switching through a collective action of cis-elements
4. Impact of Longitudinal Alcohol Use Patterns on Long-Term Risk of Cirrhosis Among US Veterans With Steatotic Liver Disease
5. Broadening Horizons: Why Gastroenterologists Should Consider a Career in Obesity Medicine
6. Outcomes of Patients with Opioid-Related Diagnoses in Acute Coronary Syndrome: a National Inpatient Sample-Based Analysis
7. Cardiovascular Disease Risk and Statin Use Among Adults with Metabolic Dysfunction Associated Fatty Liver Disease
8. Increased Mortality in Patients Undergoing Inpatient Endoscopy During the Early COVID-19 Pandemic
9. High burden of hepatocellular carcinoma and viral hepatitis in Southern and Central Vietnam: Experience of a large tertiary referral center, 2010 to 2016
10. Impact of HIV Infection on Liver and Cardiovascular Outcomes in Veterans With Metabolic Dysfunction-Associated Steatotic Liver Disease
11. Incidence of Cirrhosis and Hepatocellular Carcinoma Among Veterans With Noncirrhotic Metabolic Dysfunction-associated Fatty Liver Disease.
12. The Reply
13. Effects on the transcriptome upon deletion of a distal element cannot be predicted by the size of the H3K27Ac peak in human cells
14. Kinetics of Stem Cell Stasis and Transformation Through Transcription Factor WUSCHEL and its Interactors
15. Excess Weight Gain After Cure of Hepatitis C Infection with Direct-Acting Antivirals
16. Vitamin D and Colorectal Cancer
17. S1581 Assessing the Effectiveness of Incorporating Weight Management Treatments Into a Fatty Liver Disease Program
18. S3895 Bariatric Surgery in Decompensated NASH Cirrhosis: Pushing the Limits
19. S1361 Evaluating the Association Between Concurrent Human Immunodeficiency Virus Infection and Risk of Cardiovascular Disease in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease
20. S1360 High-Risk Alcohol Use Is Associated With Significantly Greater Risk of Incident Hepatocellular Carcinoma in a National Cohort of U.S. Veterans With Metabolic Dysfunction Associated Fatty Liver Disease
21. Medical Approach for Weight Loss in Nonalcoholic Fatty Liver Disease
22. Low real-world eligibility rates for nonalcoholic steatohepatitis patients for phase 3 clinical trial criteria application in a large academic health system
23. Exercise Does Not Independently Improve Histological Outcomes in Biopsy-Proven Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
24. Chapter 6 - Clinical diagnosis and evaluation pathway
25. Vitamin D and Colorectal Cancer
26. Lean NAFLD is associated with adverse liver events and mortality: moving beyond BMI
27. The independent effect of exercise on biopsy-proven non-alcoholic fatty liver disease: A systematic review
28. Correction to: Excess Weight Gain After Cure of Hepatitis C Infection with Direct-Acting Antivirals
29. Outcomes of Patients with Opioid-Related Diagnoses in Acute Coronary Syndrome: a National Inpatient Sample-Based Analysis
30. S1358 Nonalcoholic Fatty Liver Disease Outcomes in Patients With Comorbid Psychiatric Disorders Improved by Integrated Medical Weight Management and Hepatology Clinic Care
31. S1453 Weight Loss in Bariatric Surgery Patients Treated at a Novel Clinic Incorporating Obesity Medicine for Treatment of Nonalcoholic Fatty Liver Disease
32. S1276 Frailty Is Associated With Worse Outcomes in Patients Hospitalized With Non-Alcoholic Steatohepatitis (NASH)
33. S1345 Weight Loss Outcomes With and Without Diabetes in Patients With NAFLD in a Specialty Fatty Liver Disease Program
34. Reliability of adenoma detection rate is based on procedural volume
35. Clinical Phenotyping and the Application of Precision Medicine in MAFLD
36. The independent effect of exercise on biopsyproven non-alcoholic fatty liver disease: A systematic review.
37. Contributors
38. S1125 The Impact of Dietary Composition on Non-Alcoholic Fatty Liver Disease and Advanced Fibrosis in U.S. Adults
39. Sa623 PROVIDER KNOWLEDGE, ATTITUTDES, AND PRACTICES FOR OBESITY MANAGEMENT AMONG MEDICATION PRESCRIBERS COMPARED TO NON-PRESCRIBERS
40. 921 WEIGHING THE OPTIONS: ATTITUDES AND PERCEPTIONS OF BARIATRIC SURGERY AMONGST PROVIDERS BASED ON REFERRAL PATTERNS
41. Variants of the Adiponectin (ADIPOQ) and Adiponectin Receptor 1 (ADIPOR1) genes and colorectal cancer risk
42. Differences in resolution of mwr-containing plasmid dimers mediated by the Klebsiella pneumoniae and Escherichia coli XerC recombinases: potential implications in dissemination of antibiotic resistance genes
43. Endoscopic Retrograde Cholangiopancreatography: Deciphering the Black and White
44. Mo1571 OVERCOMING METABOLIC BARRIERS TO LIVING LIVER DONATION
45. Sa1547 IS TISSUE THE ISSUE? USE AND UTILITY OF LIVER BIOPSY IN A DEDICATED FATTY LIVER DISEASE CLINIC INCORPORATING METABOLIC HEALTH CARE
46. Sa1549 LONG-TERM INCIDENCE AND DISPARITIES IN DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN A NATIONAL COHORT OF VETERANS WITH METABOLIC DYSFUNCTION ASSOCIATED FATTY LIVER DISEASE
47. 8 RACIAL AND ETHNIC DISPARITIES IN THE LONG-TERM INCIDENCE OF CIRRHOSIS IN A NATIONAL COHORT OF VETERANS WITH METABOLIC DYSFUNCTION ASSOCIATED FATTY LIVER DISEASE
48. Drug development of nonalcoholic fatty liver disease: challenges in research, regulatory pathways, and study endpoints
49. S1016 Tolerance and Safety of Meal Replacement Program in Nonalcoholic Steatohepatitis With Fibrosis and Cirrhosis: A Case Series
50. S1015 Bariatric Surgery Can Be Performed Safely at Yale-New Haven Hospital in Patients With Cirrhosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.